ATB-1011

DRUG2 trials

Sponsors

Autotelicbio

Conditions

Diabete Type 2Diabetes Mellitus, Type 2Essential HypertensionHypertension

Phase 1

A Study to Compare the Pharmacokinetics and Safety of the ATB-U101 and ATB-U1011+ATB-U1012 and ATB-1011+ATB-1012 in Healthy Caucasian Participants

Not yet recruitingNCT07590466

AutotelicbioDiabete Type 2, Hypertension

Start: 2026-05-18End: 2026-08-31Target: 36Updated: 2026-05-15

Phase 3

Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes

CompletedNCT05573477

AutotelicbioDiabetes Mellitus, Type 2, Essential Hypertension

Start: 2022-11-16End: 2026-02-28Updated: 2026-08-27